• Thumbnail for Bruton's tyrosine kinase
    Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans...
    27 KB (2,837 words) - 12:09, 16 October 2024
  • Thumbnail for X-linked agammaglobulinemia
    develop serious and even fatal infections. A mutation occurs at the Bruton's tyrosine kinase (Btk) gene that leads to a severe block in B cell development (at...
    16 KB (1,915 words) - 13:55, 4 September 2024
  • Thumbnail for Ogden Bruton
    name: "Bruton-type agammaglobulinemia". The gene associated with this defect is also named after him: Btk, abbreviation for Bruton's tyrosine kinase. He...
    8 KB (994 words) - 15:07, 18 April 2024
  • ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes...
    12 KB (877 words) - 15:36, 25 January 2024
  • Thumbnail for Phosphoinositide 3-kinase
    been identified that are regulated by PtdIns(3,4,5)P3, including Bruton's tyrosine kinase (BTK), General Receptor for Phosphoinositides-1 (GRP1), and the...
    32 KB (3,463 words) - 17:34, 20 November 2023
  • including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November, 2024 the company announced its intention...
    26 KB (2,339 words) - 17:53, 14 November 2024
  • Thumbnail for Zanubrutinib
    Zanubrutinib (category Kinase inhibitors)
    chronic lymphocytic leukemia (CLL). Zanubrutinib is classified as a Bruton's tyrosine kinase (BTK) inhibitor. It is given by mouth. It was approved for medical...
    23 KB (1,765 words) - 02:36, 28 April 2024
  • Thumbnail for Acalabrutinib
    Acalabrutinib (category Tyrosine kinase inhibitors)
    It is a second generation Bruton's tyrosine kinase inhibitor. Acalabrutinib blocks an enzyme called Bruton's tyrosine kinase, which helps B cells to survive...
    14 KB (1,047 words) - 03:31, 31 August 2024
  • Thumbnail for Pirtobrutinib
    Pirtobrutinib (category Tyrosine kinase inhibitors)
    lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine kinase (BTK). It is taken by mouth. The most common adverse reactions...
    17 KB (1,165 words) - 07:22, 22 August 2024
  • Thumbnail for Ibrutinib
    Ibrutinib (category Tyrosine kinase inhibitors)
    proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase (BTK). Blocking BTK inhibits the B-cell receptor pathway, which...
    29 KB (2,605 words) - 21:22, 16 August 2024
  • Thumbnail for Tirabrutinib
    rheumatoid arthritis. Tirabrutinib is an irreversible inhibitor of Bruton's tyrosine kinase. Dhillon S (June 2020). "Tirabrutinib: First Approval". Drugs....
    4 KB (174 words) - 15:36, 18 April 2024
  • Thumbnail for Btk-type zinc finger
    certain eukaryotic signalling proteins. The motif is named after Bruton's tyrosine kinase (Btk), an enzyme which is essential for B cell maturation in humans...
    5 KB (651 words) - 12:20, 31 October 2024
  • Thumbnail for Eli Lilly and Company
    proto-oncogene receptor tyrosine kinase rearranged during transfection (RET) inhibitor, LOXO-305, an oral Bruton's tyrosine kinase (BTK) inhibitor, and LOXO-195...
    163 KB (15,002 words) - 03:05, 13 November 2024
  • Thumbnail for Tolebrutinib
    Tolebrutinib (category Tyrosine kinase inhibitors)
    drug that is being evaluated to treat multiple sclerosis. It is a Bruton's tyrosine kinase (BTK) inhibitor. "Tolebrutinib - Sanofi". AdisInsight. Springer...
    3 KB (81 words) - 10:34, 15 September 2024
  • ibrutinib targets the MYD88 L265P mutation induced activation of Bruton's tyrosine kinase. In a cohort study of previously treated patients, ibrutinib induced...
    59 KB (5,773 words) - 01:40, 24 October 2024
  • Thumbnail for HCK
    HCK (category Tyrosine kinases)
    Tyrosine-protein kinase HCK is an enzyme that in humans is encoded by the HCK gene. HCK comprises five distinct domains which include two terminal domains...
    20 KB (2,331 words) - 05:46, 9 May 2024
  • Thumbnail for Protein kinase D1
    cell surface.[supplied by OMIM] Protein kinase D1 has been shown to interact with: Bruton's tyrosine kinase, C1QBP, Centaurin, alpha 1, Metallothionein...
    11 KB (1,304 words) - 01:35, 27 August 2023
  • kurstaki (Btk), a soil-dwelling bacterium also used as an insecticide Bruton's tyrosine kinase, a protein Btk-type zinc finger or Btk motif (BM), a zinc-binding...
    2 KB (252 words) - 17:24, 5 September 2023
  • Thumbnail for Caveolin 1
    PDGFRA, PTGS2, TRAF2, estrogen receptor alpha, caveolin 2, PLD2, Bruton's tyrosine kinase, and SCP2. All these interactions are through a caveolin-scaffolding...
    14 KB (1,555 words) - 20:31, 22 August 2024
  • Thumbnail for Remibrutinib
    Remibrutinib (category Tyrosine kinase inhibitors)
    Remibrutinib is a small molecule drug that acts as a Bruton's tyrosine kinase (BTK) inhibitor. It is in development for the treatment of chronic spontaneous...
    5 KB (203 words) - 21:49, 24 April 2024
  • Thumbnail for Tyrosine-protein kinase SYK
    Tyrosine-protein kinase SYK, also known as spleen tyrosine kinase, is an enzyme which in humans is encoded by the SYK gene. SYK, along with ZAP70, is...
    18 KB (2,083 words) - 06:18, 25 December 2023
  • Poseltinib (HM71224, LY3337641) is an experimental Bruton's tyrosine kinase inhibitor for the treatment of rheumatoid arthritis. It was developed by Hanmi...
    3 KB (123 words) - 01:27, 6 April 2023
  • Thumbnail for ITK (gene)
    intracellular kinases: N-terminus – PH (pleckstrin homology domain) TH – Tec family homology domain (including Bruton's tyrosine kinase Cys-rich motif...
    13 KB (1,522 words) - 02:07, 5 June 2024
  • Thumbnail for Primary central nervous system lymphoma
    cases. A phase 1 clinical trial of ibrutinib – an inhibitor of Bruton's tyrosine kinase – in 13 patients reported responses in 10 (77%). Five of the responses...
    15 KB (1,557 words) - 18:36, 31 July 2024
  • Thumbnail for GTF2I
    to autoimmune disorders. GTF2I has been shown to interact with: Bruton's tyrosine kinase, HDAC3, Histone deacetylase 2, MAPK3, Myc, PRKG1, Serum response...
    14 KB (1,672 words) - 01:36, 11 December 2023
  • Thumbnail for Orelabrutinib
    Orelabrutinib (category Kinase inhibitors)
    least one treatment in the past. Orelabrutinib is an inhibitor of Bruton's tyrosine kinase. Dhillon S (March 2021). "Orelabrutinib: First Approval". Drugs...
    4 KB (122 words) - 05:58, 5 July 2024
  • Thumbnail for Nemtabrutinib
    Nemtabrutinib (category Tyrosine kinase inhibitors)
    formerly ARQ 531) is a small molecule drug that works as a reversible Bruton's tyrosine kinase (BTK) inhibitor; unlike other BTK inhibitors it also works against...
    7 KB (501 words) - 19:50, 24 April 2024
  • Thumbnail for Targeted therapy
    four different trials of VAL-083 are registered. Ibrutinib blocks Bruton's tyrosine kinase (BTK) and is used to treat mantle cell lymphoma, chronic lymphocytic...
    20 KB (2,234 words) - 01:21, 22 July 2024
  • bacterial infections. XLA is associated with a mutation in the Bruton's tyrosine kinase (BTK) gene on the X chromosome, which is responsible for producing...
    19 KB (2,366 words) - 09:55, 19 September 2024
  • Thumbnail for B-cell linker
    may have tumor suppressive activity through its interaction with Bruton's tyrosine kinase (Btk) and regulation of the pre-B cell checkpoint. The acidic region...
    24 KB (2,759 words) - 14:46, 26 January 2024